Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Background
Shock is a life-threatening condition resulting from inadequate circulatory capacity; this consequently results in poor tissue perfusion and oxygenation. This leads to blocking cellular functions and in turn damages the organs of the human body. In the early stages, shock may be completely counteracted, but if there is a delay in diagnosis or treatment, it may evolve to the status of irreversible damage and lead to multiorgan failure and death.Â
Epidemiology
Based on the cause, distributive shock is the most common type of shock, while hypovolemic and cardiogenic shocks are less common. Obstructive shock is rarer. The most common distributive shock is the septic shock; this type of shock has a high mortality index of 40-50%.Â
Anatomy
Pathophysiology
Cellular hypoxia initiates metabolic and biochemical modifications resulting into acidosis and low regional blood flow that worsens territorial hypoxia. Hypovolemic, obstructive, and cardiogenic shock are associated with reduced cardiac output and oxygen delivery, while distributive shock is defined by decreased peripheral resistance and impaired tissue oxygen utilization. Shock goes through a number of physiological steps, which are reversible in the initial stages and final stages are irreversible, which may lead to multiple organ dysfunction and mortality.
The three stages of shock are:Â
Etiology
It is a clinical condition in which there is either tissue hypoxia because of low oxygen delivery or high oxygen demand in tissues. This potentially fatal circulatory dysfunction is characterized by hypotension, with systolic blood pressure below 90 mm Hg, or Mean arterial pressure below 65 mm Hg. It may be caused by many factors and may lead to death if left untreated. It is classified into four main types: are distributive, hypovolemic, cardiogenic, and obstructive.Â
Types of Shock:Â
Genetics
Prognostic Factors
Sepsis and septic shock are associated with both short and long-term combined mortalities, and many survivors require further care in long-term acute care hospitals or post-acute care facilities. The mortality of the septic shock stands at a shocking 40 to 50 percent. Cardiogenic shock has a relatively higher mortality ratio estimated at 50-75% although this has been observed to be lowering gradually in the recent past. Hypovolemic and obstructive shock on the other hand, often come with relatively lower mortality rates, and are usually more sensitive to treatment measures.Â
Clinical History
Distributive Shock:Â
Hypovolemic Shock:Â
Cardiogenic Shock:Â
Obstructive Shock:Â
Physical Examination
Age group
Associated comorbidity
These include pulmonary embolism, tension pneumothorax, pericardial tamponade.
Associated activity
Acuity of presentation
Sharp; occurs abruptly because of blockages or problems with the pressure.Â
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
General Principles: Determine the type of shock and its source based on the patient’s history, examination, and further testing. ABC’s should be checked and secured.Â
Fluid Resuscitation: Give intravenous fluid therapy (for example isotonic fluids such as normal saline or Ringer’s lactate) to replenish intravascular volume and enhance tissue perfusion. The patient should also have their fluid levels checked constantly and periodically changed depending on their reaction to the new fluid levels and presence of clinical signs of fluid overload.Â
Vasopressor and Inotropic Support: They are used to raise blood pressure and optimize blood flow to tissues (e. g. norepinephrine, vasopressin, epinephrine). Enhance myocardial contractility in conditions of cardiogenic shock (for example, dobutamine, milrinone).Â
Addressing the Underlying CauseÂ
Supportive TherapiesÂ
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-a-non-pharmacological-approach-for-treating-shock
Role of Isotonic Crystalloids
Role of Vasopressors
Role of Antibiotics
use-of-intervention-with-a-procedure-in-treating-shock
Fluid Resuscitation: In shock, especially hypovolemic shock, the general management strategy involves the administration of fluids through a vascular access route. Crystalloids such as normal saline, lactated Ringer’s solution are often employed while colloids like hydroxyethyl starch may be administered in certain situations.Â
Vasopressor Therapy: For instance, there is utilization of drugs such as Norepinephrine, Epinephrine, and dopamine to help raising blood pressure and hence enhance perfusion. These are particularly relevant in septic shock or cardiogenic shocks where there is inadequate adequate fluid load.Â
Inotropic Agents: The treatments for cardiogenic shock include drugs like dobutamine or milrinone to enhance the strength of heart contraction or cardiac output respectively.Â
Central Venous Pressure Monitoring:Â
use-of-phases-in-managing-shock
Medication
Post-Cardiotomy Shock-
0.03 units/minute intravenously initially.
Titrate up to 0.005 unit/minute at an interval of 10-15 minutes, until the required blood pressure is achieved.
Septic Shock-
0.01 units/minute intravenously initially.
Titrate up to 0.005 unit/minute at an interval of 10-15 minutes, until the required blood pressure is achieved.
Note:
It is used to raise blood pressure in patients with vasodilatory shock (such as those who have had a cardiotomy or who have sepsis) who are still hypotensive despite receiving fluids and catecholamines.
1-6 mg/kg intravenously once, or
40 mg intravenously every 2-6 hours as required
Alternatively, 20 mg intravenously, later 3 mg/kg per day intravenously
Do not continue high dose treatment more than 48-72 hours
synthetic human angiotensin IIÂ
Indicated for Shock
Initial dose: 20ng/Kg/min intravenously by constant infusion
Titration dose: Check the blood pressure levels and titrate every 5 minutes up to 15 ng/kg/min as needed to achieve the desired blood pressure levels. Should not exceed 80 ng/kg/min while the first 3 hours of the treatment
Maintenance dose: dose as low as 1.25 ng/kg/min. Should not exceed 40 ng/kg/min
After the improvement of the Shock condition, titrate downward every 5-15 minutes up to 15 ng/kg/min, depending upon blood pressure levels
Administration through the central venous line is generally recommended
Note:
It is indicated to enhance blood pressure levels in adults with septic or distributive shock
Indicated for severe shock
Initially, 0.5-5 mg through direct injection, after infusion of 15-100 mg in 0.5 L of diluent
Indicated for Plasma volume expander for hypovolaemic shock
10% preparation: The suggested dose range is 500 ml to 1000 ml. The maximum dose is 1500 ml in a day
6% preparation: The suggested dose range is 500 ml to 1000 ml. The maximum dose is 2500 ml in a day
Note:
Given as a solution of normal saline/other electrolytes. The rate of infusion based on the quantity of fluid lost and the degree of haemoconcentration
Indicated for Severe Hypotension or Shock
Intravenous bolus: 40-100 mcg every 1-2 minutes as needed. Should not exceed the total dose 200 mcg
Adjust the dosage depending on the blood pressure levels
Continuous intravenous infusion: If the blood pressure levels are less than the target levels, start a continuous intravenous infusion of 10-35 mcg/min. Should not exceed 200 mcg/min
Note:
Renal impairment
End-stage renal disease: Data of dose-response indicate enhanced responsiveness to the phenylephrine
Mild-moderate: Start at low dose of the recommended dose and thereafter adjust the dose depending on blood pressure levels
Hepatic impairment
Moderate-severe: Data of dose-response indicate diminished responsiveness to the phenylephrine
Indicated for treating heart problems and imbalances in shock caused by infections, injuries, septicemia, surgery, kidney issues, or heart failure
Continuous infusion:
Initial dose: 2-10 mcg/kg/min intravenously (IV)
Maintenance dose: 2-50 mcg/kg/min intravenously (IV)
A maximum of up to 2000ml intravenously Indications: It is also indicated in isolated organ perfusion as a carrier for the infusion of insulin. It is used to treat hypovolemic shock
0.05-0.1 mcg/kg/min Intravenous infusion; titrate to the effect; should not exceed more than 2 mcg/kg/min
Indicated for Severe Hypotension or Shock as off-label
Age >2 years
5-20 mcg/kg intravenously one time; then after 0.1-0.5 mcg/kg/min intravenously. Should not exceed 3-5 mcg/kg/min intravenously
Age <2 years
Safety and efficacy not established
0.05 mcg/kg/min to 0.1 mcg/kg/min intravenous infusion
It should not exceed 2 mcg/kg/min
Future Trends
References
Shock is a life-threatening condition resulting from inadequate circulatory capacity; this consequently results in poor tissue perfusion and oxygenation. This leads to blocking cellular functions and in turn damages the organs of the human body. In the early stages, shock may be completely counteracted, but if there is a delay in diagnosis or treatment, it may evolve to the status of irreversible damage and lead to multiorgan failure and death.Â
Based on the cause, distributive shock is the most common type of shock, while hypovolemic and cardiogenic shocks are less common. Obstructive shock is rarer. The most common distributive shock is the septic shock; this type of shock has a high mortality index of 40-50%.Â
Cellular hypoxia initiates metabolic and biochemical modifications resulting into acidosis and low regional blood flow that worsens territorial hypoxia. Hypovolemic, obstructive, and cardiogenic shock are associated with reduced cardiac output and oxygen delivery, while distributive shock is defined by decreased peripheral resistance and impaired tissue oxygen utilization. Shock goes through a number of physiological steps, which are reversible in the initial stages and final stages are irreversible, which may lead to multiple organ dysfunction and mortality.
The three stages of shock are:Â
It is a clinical condition in which there is either tissue hypoxia because of low oxygen delivery or high oxygen demand in tissues. This potentially fatal circulatory dysfunction is characterized by hypotension, with systolic blood pressure below 90 mm Hg, or Mean arterial pressure below 65 mm Hg. It may be caused by many factors and may lead to death if left untreated. It is classified into four main types: are distributive, hypovolemic, cardiogenic, and obstructive.Â
Types of Shock:Â
Sepsis and septic shock are associated with both short and long-term combined mortalities, and many survivors require further care in long-term acute care hospitals or post-acute care facilities. The mortality of the septic shock stands at a shocking 40 to 50 percent. Cardiogenic shock has a relatively higher mortality ratio estimated at 50-75% although this has been observed to be lowering gradually in the recent past. Hypovolemic and obstructive shock on the other hand, often come with relatively lower mortality rates, and are usually more sensitive to treatment measures.Â
Distributive Shock:Â
Hypovolemic Shock:Â
Cardiogenic Shock:Â
Obstructive Shock:Â
These include pulmonary embolism, tension pneumothorax, pericardial tamponade.
Sharp; occurs abruptly because of blockages or problems with the pressure.Â
General Principles: Determine the type of shock and its source based on the patient’s history, examination, and further testing. ABC’s should be checked and secured.Â
Fluid Resuscitation: Give intravenous fluid therapy (for example isotonic fluids such as normal saline or Ringer’s lactate) to replenish intravascular volume and enhance tissue perfusion. The patient should also have their fluid levels checked constantly and periodically changed depending on their reaction to the new fluid levels and presence of clinical signs of fluid overload.Â
Vasopressor and Inotropic Support: They are used to raise blood pressure and optimize blood flow to tissues (e. g. norepinephrine, vasopressin, epinephrine). Enhance myocardial contractility in conditions of cardiogenic shock (for example, dobutamine, milrinone).Â
Addressing the Underlying CauseÂ
Supportive TherapiesÂ
Emergency Medicine
Emergency Medicine
Emergency Medicine
Emergency Medicine
Emergency Medicine
Fluid Resuscitation: In shock, especially hypovolemic shock, the general management strategy involves the administration of fluids through a vascular access route. Crystalloids such as normal saline, lactated Ringer’s solution are often employed while colloids like hydroxyethyl starch may be administered in certain situations.Â
Vasopressor Therapy: For instance, there is utilization of drugs such as Norepinephrine, Epinephrine, and dopamine to help raising blood pressure and hence enhance perfusion. These are particularly relevant in septic shock or cardiogenic shocks where there is inadequate adequate fluid load.Â
Inotropic Agents: The treatments for cardiogenic shock include drugs like dobutamine or milrinone to enhance the strength of heart contraction or cardiac output respectively.Â
Central Venous Pressure Monitoring:Â
Emergency Medicine
Shock is a life-threatening condition resulting from inadequate circulatory capacity; this consequently results in poor tissue perfusion and oxygenation. This leads to blocking cellular functions and in turn damages the organs of the human body. In the early stages, shock may be completely counteracted, but if there is a delay in diagnosis or treatment, it may evolve to the status of irreversible damage and lead to multiorgan failure and death.Â
Based on the cause, distributive shock is the most common type of shock, while hypovolemic and cardiogenic shocks are less common. Obstructive shock is rarer. The most common distributive shock is the septic shock; this type of shock has a high mortality index of 40-50%.Â
Cellular hypoxia initiates metabolic and biochemical modifications resulting into acidosis and low regional blood flow that worsens territorial hypoxia. Hypovolemic, obstructive, and cardiogenic shock are associated with reduced cardiac output and oxygen delivery, while distributive shock is defined by decreased peripheral resistance and impaired tissue oxygen utilization. Shock goes through a number of physiological steps, which are reversible in the initial stages and final stages are irreversible, which may lead to multiple organ dysfunction and mortality.
The three stages of shock are:Â
It is a clinical condition in which there is either tissue hypoxia because of low oxygen delivery or high oxygen demand in tissues. This potentially fatal circulatory dysfunction is characterized by hypotension, with systolic blood pressure below 90 mm Hg, or Mean arterial pressure below 65 mm Hg. It may be caused by many factors and may lead to death if left untreated. It is classified into four main types: are distributive, hypovolemic, cardiogenic, and obstructive.Â
Types of Shock:Â
Sepsis and septic shock are associated with both short and long-term combined mortalities, and many survivors require further care in long-term acute care hospitals or post-acute care facilities. The mortality of the septic shock stands at a shocking 40 to 50 percent. Cardiogenic shock has a relatively higher mortality ratio estimated at 50-75% although this has been observed to be lowering gradually in the recent past. Hypovolemic and obstructive shock on the other hand, often come with relatively lower mortality rates, and are usually more sensitive to treatment measures.Â
Distributive Shock:Â
Hypovolemic Shock:Â
Cardiogenic Shock:Â
Obstructive Shock:Â
These include pulmonary embolism, tension pneumothorax, pericardial tamponade.
Sharp; occurs abruptly because of blockages or problems with the pressure.Â
General Principles: Determine the type of shock and its source based on the patient’s history, examination, and further testing. ABC’s should be checked and secured.Â
Fluid Resuscitation: Give intravenous fluid therapy (for example isotonic fluids such as normal saline or Ringer’s lactate) to replenish intravascular volume and enhance tissue perfusion. The patient should also have their fluid levels checked constantly and periodically changed depending on their reaction to the new fluid levels and presence of clinical signs of fluid overload.Â
Vasopressor and Inotropic Support: They are used to raise blood pressure and optimize blood flow to tissues (e. g. norepinephrine, vasopressin, epinephrine). Enhance myocardial contractility in conditions of cardiogenic shock (for example, dobutamine, milrinone).Â
Addressing the Underlying CauseÂ
Supportive TherapiesÂ
Emergency Medicine
Emergency Medicine
Emergency Medicine
Emergency Medicine
Emergency Medicine
Fluid Resuscitation: In shock, especially hypovolemic shock, the general management strategy involves the administration of fluids through a vascular access route. Crystalloids such as normal saline, lactated Ringer’s solution are often employed while colloids like hydroxyethyl starch may be administered in certain situations.Â
Vasopressor Therapy: For instance, there is utilization of drugs such as Norepinephrine, Epinephrine, and dopamine to help raising blood pressure and hence enhance perfusion. These are particularly relevant in septic shock or cardiogenic shocks where there is inadequate adequate fluid load.Â
Inotropic Agents: The treatments for cardiogenic shock include drugs like dobutamine or milrinone to enhance the strength of heart contraction or cardiac output respectively.Â
Central Venous Pressure Monitoring:Â
Emergency Medicine

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
